skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar solo
Refinado por: materia: Medical Sciences eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial
0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial
Material Type:
Artículo 		Añadir a Mi Portal

0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial

REITAMO, S ; HARPER, J ; BOS, J. D ; CAMBAZARD, F ; BRUIJNZEEL-KOOMEN, C ; VALK, P ; SMITH, C ; MOSS, C ; VOBOZY, A ; PALATSI, R

British journal of dermatology (1951), 2004-03, Vol.150 (3), p.554-562 [Revista revisada por pares]

London: Blackwell

Texto completo disponible

Citas Citado por
2
0.2% Chlorhexidine Mouthwash With an Antidiscoloration System Versus 0.2% Chlorhexidine Mouthwash: A Prospective Clinical Comparative Study
0.2% Chlorhexidine Mouthwash With an Antidiscoloration System Versus 0.2% Chlorhexidine Mouthwash: A Prospective Clinical Comparative Study
Material Type:
Artículo 		Añadir a Mi Portal

0.2% Chlorhexidine Mouthwash With an Antidiscoloration System Versus 0.2% Chlorhexidine Mouthwash: A Prospective Clinical Comparative Study

Solís, Carols ; Santos, Antonio ; Nart, José ; Violant, Deborah

Journal of periodontology (1970), 2011-01, Vol.82 (1), p.80-85 [Revista revisada por pares]

Chicago, IL: American Academy of Periodontology

Texto completo disponible

Citas Citado por
3
0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease
0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease
Material Type:
Artículo 		Añadir a Mi Portal

0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease

Okabe, Shingo ; Ugawa, Yoshikazu ; Kanazawa, Ichiro

Movement disorders, 2003-04, Vol.18 (4), p.382-388 [Revista revisada por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponible

Citas Citado por
4
0.2% ropivacaine with or without Fentanyl for Patient-Controlled Epidural Analgesia after Major abdominal Surgery: a Double-Blind Study
0.2% ropivacaine with or without Fentanyl for Patient-Controlled Epidural Analgesia after Major abdominal Surgery: a Double-Blind Study
Material Type:
Artículo 		Añadir a Mi Portal

0.2% ropivacaine with or without Fentanyl for Patient-Controlled Epidural Analgesia after Major abdominal Surgery: a Double-Blind Study

Berti, Marco ; Casati, Andrea ; Fanelli, Guido ; Albertin, Andrea ; Palmisano, Sara ; Danelli, Giorgio ; Comotti, Laura ; Torri, Giorgio

Journal of clinical anesthesia, 2000-06, Vol.12 (4), p.292-297 [Revista revisada por pares]

New York, NY: Elsevier Inc

Texto completo disponible

Citas Citado por
5
0.25 % prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1 % betamethasone-17-valerate cream and 0.05 % clobetasol-17-propionate cream
0.25 % prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1 % betamethasone-17-valerate cream and 0.05 % clobetasol-17-propionate cream
Material Type:
Artículo 		Añadir a Mi Portal

0.25 % prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1 % betamethasone-17-valerate cream and 0.05 % clobetasol-17-propionate cream

KORTING, H. C ; VIELUF, D ; KERSCHER, M

European journal of clinical pharmacology, 1992-02, Vol.42 (2), p.159-161 [Revista revisada por pares]

Heidelberg: Springer

Texto completo disponible

Citas Citado por
6
0.3% tacrolimus gel and 0.5% tacrolimus cream show efficacy in mild to moderate plaque psoriasis : Results of a randomized, open-label, observer-blinded study
0.3% tacrolimus gel and 0.5% tacrolimus cream show efficacy in mild to moderate plaque psoriasis : Results of a randomized, open-label, observer-blinded study
Material Type:
Artículo 		Añadir a Mi Portal

0.3% tacrolimus gel and 0.5% tacrolimus cream show efficacy in mild to moderate plaque psoriasis : Results of a randomized, open-label, observer-blinded study

ORTONNE, Jean-Paul ; VAN DE KERKHOF, Peter C. M ; PRINZ, Jorg C ; BIEBER, Thomas ; LAHFA, Morad ; RUBINS, Andris ; WOZEL, Gottfried ; LORETTE, Gerard

Acta dermato-venereologica, 2006-01, Vol.86 (1), p.29-33 [Revista revisada por pares]

Uppsala: Acta dermato-venereologica

Texto completo disponible

Citas Citado por
7
0.5% Versus 1.0% 2-chloroprocaine for intravenous regional anesthesia: A prospective, randomized, double-blind trial
0.5% Versus 1.0% 2-chloroprocaine for intravenous regional anesthesia: A prospective, randomized, double-blind trial
Material Type:
Artículo 		Añadir a Mi Portal

0.5% Versus 1.0% 2-chloroprocaine for intravenous regional anesthesia: A prospective, randomized, double-blind trial

MARSCH, Stephan C ; SLUGA, Mathias ; STUDER, Wolfgang ; BARANDUN, Jonas ; SCHARPLATZ, Domenic ; UMMENHOFER, Wolfgang

Anesthesia and analgesia, 2004-06, Vol.98 (6), p.1789-1793 [Revista revisada por pares]

Hagerstown, MD: Lippincott

Texto completo disponible

Citas Citado por
8
1-[1-(2-Benzo[ b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vivo : Identification and quantification of BTCP primary metabolites in mice plasma, urine, and brain and their affinity for the neuronal dopamine transporter
1-[1-(2-Benzo[ b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vivo : Identification and quantification of BTCP primary metabolites in mice plasma, urine, and brain and their affinity for the neuronal dopamine transporter
Material Type:
Artículo 		Añadir a Mi Portal

1-[1-(2-Benzo[ b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vivo : Identification and quantification of BTCP primary metabolites in mice plasma, urine, and brain and their affinity for the neuronal dopamine transporter

Deleuze-Masquefa, Carine ; Michaud-Dutreilh, Martine ; Vignon, Jacques ; Kamenka, Jean-Marc

European journal of pharmaceutical sciences, 2000-02, Vol.9 (4), p.345-354 [Revista revisada por pares]

Shannon: Elsevier B.V

Texto completo disponible

Citas Citado por
9
1, 1, 2-TRICHLOROETHANE: EVIDENCE OF GENOTOXICITY FROM SHORT-TERM TESTS
1, 1, 2-TRICHLOROETHANE: EVIDENCE OF GENOTOXICITY FROM SHORT-TERM TESTS
Material Type:
Artículo 		Añadir a Mi Portal

1, 1, 2-TRICHLOROETHANE: EVIDENCE OF GENOTOXICITY FROM SHORT-TERM TESTS

MAZZULLO, Mario ; COLACCI, Annamaria ; GRILLI, Sandro ; PRODI, Giorgio ; ARFELLINI, Giancarlo

Japanese Journal of Cancer Research GANN, 1986, Vol.77(6), pp.532-539

Tokyo: The Japanese Cancer Association

Texto completo disponible

Citas Citado por
10
1-(1-naphthyl)-piperazine, a mixed 5-HT1A and 5-HT2A/2C receptor ligand, elicits an anxiolytic-like effect in the open-field test without changes in 5-HT metabolism
1-(1-naphthyl)-piperazine, a mixed 5-HT1A and 5-HT2A/2C receptor ligand, elicits an anxiolytic-like effect in the open-field test without changes in 5-HT metabolism
Material Type:
Artículo 		Añadir a Mi Portal

1-(1-naphthyl)-piperazine, a mixed 5-HT1A and 5-HT2A/2C receptor ligand, elicits an anxiolytic-like effect in the open-field test without changes in 5-HT metabolism

PRUUS, K ; RUDISAAR, R ; VAARMANN, A ; MATTO, V ; ALLIKMETS, L

Methods and findings in experimental and clinical pharmacology, 2002-04, Vol.24 (3), p.151-157 [Revista revisada por pares]

Barcelona: Prous

Texto completo disponible

Citas Citado por
Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Revistas arbitradas (1.387.291)

Refinar mis resultados

Tipo de Recurso 

  1. Artículos  (1.467.323)
  2. Actas de Congreso  (326)
  3. magazinearticle  (15)
  4. Capítulos de libro  (9)
  5. Libros  (4)
  6. Tesis  (2)
  7. Conjunto de Datos  (2)
  8. Más opciones open sub menu

Materia 

  1. Biological And Medical Sciences  (1.467.411)
  2. Male  (1.459.082)
  3. Science & Technology  (1.325.023)
  4. Life Sciences & Biomedicine  (1.318.274)
  5. Humans  (1.256.307)
  6. Female  (1.032.279)
  7. Adult  (708.281)
  8. Middle Aged  (707.748)
  9. Aged  (495.489)
  10. Adolescent  (279.045)
  11. Animals  (256.056)
  12. Pharmacology. Drug Treatments  (249.491)
  13. Child  (185.102)
  14. Neurosciences & Neurology  (170.276)
  15. Aged, 80 And Over  (169.710)
  16. Psychology. Psychoanalysis. Psychiatry  (161.781)
  17. Surgery  (159.777)
  18. Rats  (143.659)
  19. Treatment Outcome  (138.833)
  20. Más opciones open sub menu

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de1982  (26)
  2. 1982Hasta1991  (211.766)
  3. 1992Hasta2001  (467.274)
  4. 2002Hasta2012  (719.584)
  5. Después de 2012  (69.035)
  6. Más opciones open sub menu

Idioma 

  1. Inglés  (1.467.680)
  2. Japonés  (259.543)
  3. Alemán  (899)
  4. Portugués  (696)
  5. Francés  (466)
  6. Español  (37)
  7. Persa  (27)
  8. Chino  (19)
  9. Sueco  (17)
  10. Ruso  (11)
  11. Welsh  (9)
  12. Faroese  (2)
  13. Noruego  (2)
  14. Afrikaans  (2)
  15. Danés  (2)
  16. Serbian  (1)
  17. Thai  (1)
  18. Italiano  (1)
  19. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora